Research Data Policy

Research Data Policy

The Journal of Community Pharmacy Practice encourages research transparency and reproducibility. Authors are required to include a Data Availability Statement in all submitted manuscripts.

Where to include the statement

The Data Availability Statement appears as a labelled section at the end of the manuscript, immediately before the References.

Acceptable statement formats

Authors should select the format most accurate for their study:

• “The datasets generated and analysed during the current study are available from the corresponding author upon reasonable request.”
• “All data generated or analysed during this study are included in this published article [and its supplementary information files].”
• “The datasets generated and/or analysed during the current study are available in [repository name] at [DOI/URL].”
• “The study used anonymised and aggregated routinely collected dispensing data under a Data Use Agreement. Individual-level data cannot be shared due to patient confidentiality requirements under [applicable law/regulation].”
• “No new data were generated or analysed in support of this research (review article).”

Patient data and privacy

Research involving patient data (dispensing records, prescription data, electronic health records) must confirm that data are anonymised or pseudonymised in compliance with applicable national privacy legislation (e.g., PDPA, HIPAA, GDPR) and that appropriate data use agreements are in place. Where sharing of underlying patient data is not possible for ethical or legal reasons, this must be clearly stated with the reason given.

Open data encouraged

Where patient data restrictions do not apply, authors are encouraged to deposit research datasets in publicly accessible repositories (Zenodo, Figshare, Harvard Dataverse, OSF) and provide a persistent DOI.